Legal Representation
Attorney
Andrew D. Price & Paula E. Hopkins
USPTO Deadlines
Next Deadline
964 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-02-27)
Due Date
February 27, 2028
Grace Period Ends
August 27, 2028
Application History
28 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 30, 2024 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Nov 30, 2024 | C15P | O | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Nov 30, 2024 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Nov 20, 2024 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Jun 20, 2024 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
| Feb 27, 2023 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Dec 28, 2022 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Feb 27, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Dec 12, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 12, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Nov 22, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 8, 2017 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE |
| Nov 3, 2017 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Oct 31, 2017 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 25, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Oct 25, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Oct 25, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Oct 25, 2017 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Sep 30, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 30, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 26, 2017 | ALIE | A | ASSIGNED TO LIE |
| Sep 19, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 22, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 22, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 22, 2017 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 14, 2017 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 15, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 15, 2016 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer, infectious diseases and autoimmune diseases; biological preparations for the treatment of cancer; biological preparations for medical use for the treatment of cancer, infectious diseases and autoimmune diseases; immunotherapeutic drugs; reagents for medical use; Biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; diagnostic preparations for medical purposes; diagnostic reagents for medical use
Class 042
[Pharmaceutical testing and clinical trials for others; provision of information and consultancy in relation to the aforesaid services; scientific and technological services, namely, research and design in the field of drug development for the treatment of cancer, infectious diseases and autoimmune diseases; pharmaceutical research and development services; research and development in the biotechnology field; provision of information and consultancy in relation to the aforesaid services]
Classification
International Classes
005
042